fbpx

Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation

Cannabinoid hyperemesis syndrome (CHS) is a diagnosis of exclusion with intractable nausea, cy- clic vomiting, abdominal pain, and hot bathing behavior associated with ongoing tetrahydrocannabinol (THC) exposure. Increasing cannabis use may elevate CHS prevalence, exacerbating a public health issue with atten- dant costs and morbidity.

The post Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation appeared first on Society of Cannabis Clinicians.

Leave a Reply

%d bloggers like this: